J. Scott Andrews - Concepedia

Author

J. Scott Andrews

Also Known As

Andrews, Jeffrey S., J Scott Andrews, J. Andrews, J. Scott Andrews, J.S. Andrews, Jeffrey Andrews, Jeffrey S. Andrews, Jeffrey Scott Andrews

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Analysis Group (United States)Harvard University Massachusetts General Hospital Brigham and Women's Hospital

About

J. Scott Andrews is an author at Eli Lilly (United States) specializing in medicine, health policy, and health services research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	81
2	Health Policy	2	2	61
3	Health Sciences	1	1	28
4	Public Health	1	1	33
5	Geriatrics	1	1	20

J. Scott Andrews

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, Alzheimer s & Dementia	2024	1.7K
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials J. Scott Andrews, Urvi Desai, Noam Y. Kirson, Alzheimer s & Dementia Translational Research & Clinical Interventions	2019	313
Expectations and clinical meaningfulness of randomized controlled trials Ronald C. Petersen, Paul Aisen, J. Scott Andrews, Alzheimer s & Dementia	2023	82
Costs of Early Stage Alzheimer’s Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1 R.L. Robinson, Dorene M. Rentz, J. Scott Andrews, Journal of Alzheimer s Disease	2020	69
Factors associated with long-term impact on informal caregivers during Alzheimer’s disease dementia progression: 36-month results from GERAS Catherine Reed, Mark Belger, J. Scott Andrews, International Psychogeriatrics	2019	61
Trends in health service use and potentially avoidable hospitalizations before Alzheimer's disease diagnosis: A matched, retrospective study of US Medicare beneficiaries Urvi Desai, Noam Y. Kirson, Wenyu Ye, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring	2019	53
One‐Year Effect of the Medicare Annual Wellness Visit on Detection of Cognitive Impairment: A Cohort Study Nicole R. Fowler, Noll L. Campbell, Gerhardt Pohl, Journal of the American Geriatrics Society	2018	50
Identifying factors of activities of daily living important for cost and caregiver outcomes in Alzheimer's disease Catherine Reed, Mark Belger, Bruno Vellas, International Psychogeriatrics	2015	49
Assessing the economic burden of Alzheimer’s disease patients first diagnosed by specialists Noam Y. Kirson, Urvi Desai, Ljubica Ristovska, BMC Geriatrics	2016	47
Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective Ronald C. Wielage, Megha Bansal, J. Scott Andrews, Applied Health Economics and Health Policy Cost-utility AnalysisHealth PolicyHealth EconomicsOsteoarthritisOrthopaedics	2013	33

Page 1